Charles River Laboratories International news
The WiseView Research desk's stories that name Charles River Laboratories International, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The CRL page →
- HeadlineCharles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?
- HeadlineCharles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
- Market closeS&P 500, Dow and Nasdaq Close Higher as Tech Leads Wednesday Rally
The S&P 500 rose 0.59%, the Dow 0.69% and the Nasdaq led with a 1.05% gain Wednesday, as technology stocks paced the advance.
- HeadlineCharles River Gains 75.8% in a Year: What's Driving the Rally?
- HeadlineCharles River and Autolomous Partner to Transform Laboratory Execution Systems
- CongressJefferson Shreve bought $15,001 - $50,000 of CRL
- CongressJefferson Shreve sold $15,001 - $50,000 of CRL
- CongressRob Bresnahan sold $1,001 - $15,000 of CRL
- CongressRob Bresnahan bought $15,001 - $50,000 of CRL
- CongressJulie Johnson bought $1,001 - $15,000 of CRL
- CongressRo Khanna bought $1,001 - $15,000 of CRL
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.